Mycoplasma pneumoniae: Usual suspect and unsecured Diagnosis in the acute setting

Journal of Emergency Medicine

Volumn 30, Issue 4, 2006, Pages 371-375

  Braun, Gerald S ^a   Wagner, Katrin S ^b   Huttner, Benedikt D ^c   Schmid, Holger ^d  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c Hospital Epidemiology   (Switzerland)

^d NONE

Author keywords

atypical pneumonia; Mycoplasma pneumoniae; pharyngitis; upper airway infection

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; LABORATORY DIAGNOSIS; MYCOPLASMA PNEUMONIAE; PHARYNGITIS; PNEUMONIA; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; COUGH; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; MYCOPLASMA PNEUMONIAE; PHARYNGITIS; PNEUMONIA, MYCOPLASMA;

EID: 33646873017     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2005.07.015     Document Type: Article

References (24)

1. Clyde Jr. W.A. Clinical overview of typical mycoplasma pneumoniae infections. Clin Infect Dis 17 (1993) S32-S36
2. Bartlett J.G., Dowell S.F., Mandell L.A., File Jr. T.M., Musher D.M., Fine M.J., and Guidelines from the Infectious Diseases Society of America. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis 31 (2000) 347-382
3. th edn. (2000), Churchill Livingstone, Philadelphia, PA 2018-2027
4. th edn. (2000), Churchill Livingstone, Philadelphia, PA 656-661
5. Bartlett J.G., and Mundy L.M. Community-acquired pneumonia. N Engl J Med 333 (1995) 1618-1624
6. Marrie T.J., Poulin-Costello M., Beecroft M.D., and Herman-Gnjidic Z. Etiology of community-acquired pneumonia treated in an ambulatory setting. Respir Med 99 (2005) 60-65
7. The Community-Based Pneumonia Incidence StudyGroup, Marston B.J., Plouffe J.F., File Jr. T.M., et al. Incidence of community-acquired pneumonia requiring hospitalization. results of a population-based active surveillance study in Ohio. Arch Intern Med 157 (1997) 1709-1718
8. Foy H.M. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17 Suppl 1 (1993) S37-S46
9. Foy H.M. Mycoplasma pneumoniae pneumonia. current perspectives. Clin Infect Dis 28 (1999) 237
10. Waites K.B., and Talkington D.F. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17 (2004) 697-728
11. Gennis P., Gallagher J., Falvo C., Baker S., and Than W. Clinical criteria for the detection of pneumonia in adults. guidelines for ordering chest roentgenograms in the emergency department. J Emerg Med 7 3 (1989) 263-268
12. Schalock P.C., and Dinulos J.G. Mycoplasma pneumoniae-induced Stevens-Johnson syndrome without skin lesions. fact or fiction?. J Am Acad Dermatol 52 (2005) 312-315
13. Cherry J.D. Anemia and mucocutaneous lesions due to Mycoplasma pneumoniae infections. Clin Infect Dis 17 Suppl 1 (1993) 47-51
14. Leaute-Labreze C., Lamireau T., Chawki D., Maleville J., and Taieb A. Diagnosis, classification, and management of erythema multiforme and Stevens-Johnson syndrome. Arch Dis Child 83 (2000) 347-352
15. Auquier-Dunant A., Mockenhaupt M., Naldi L., et al. Correlation between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. results of an international prospective study. Arch Dermatol 138 (2002) 1019-1024
16. Roujeau J.C., Kelly J.P., Naldi L., et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333 (1995) 1600-1607
17. Garcia-Doval I., LeCleach L., Bocquet H., Otero X.L., and Roujeau J.C. Toxic epidermal necrolysis and Stevens-Johnson Syndrome. does early withdrawal of causative drugs decrease the risk of death?. Arch Dermatol 136 (2000) 323-327
18. Jacobs E. Serological diagnosis of Mycoplasma pneumoniae infections. a critical review of current procedures. Clin Infect Dis 17 Suppl 1 (1993) S79-S82
19. Lind K., Benzon M.W., Jensen J.S., and Clyde Jr. W.A. A seroepidemiological study of Mycoplasma pneumoniae infections in Denmark over the 50-year period 1946-1995. Eur J Epidemiol 13 (1997) 581-586
20. Uldum S.A., Jensen J.S., Sondergard-Andersen J., and Lind K. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J Clin Microbiol 30 (1992) 1198-1204
21. Thacker W.L., and Talkington D.F. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 7 (2000) 778-780
22. Plouffe J.F. Importance of atypical pathogens of community-acquired pneumonia. Clin Infect Dis 31 Suppl 2 (2000) S35-S39
23. Fine M.J., Auble T.E., Yealy D.M., et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336 (1997) 243-250
24. British Thoracic Society Standards of Care Committee. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 56 Suppl 4 (2001) IV1-IV64